Study: Cholesterol was lowered with an oral PCSK9 inhibitor.

Published Date: 08 Mar 2023

A new study conducted by Baylor College of Medicine and presented at the American College of Cardiology Annual Scientific Session as well as the World Congress of Cardiology shows that an oral PCSK9 inhibitor called MK-0616...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

For the first time in humans, a chemotherapy drug reaches the brain.

2.

unhealthy sleeping habits and the risk of esophageal adenocarcinoma.

3.

FDA Expands Durvalumab Label to Operable Lung Cancer

4.

Adjuvant ICIs: A Winner and a Loser in Clear Cell Renal Cell Carcinoma?

5.

A global study demonstrates that screening for lung cancer significantly raises the long-term survival rate.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot